232 filings
Page 2 of 12
8-K
n0zphht4
30 May 23
Departure of Directors or Certain Officers
5:00pm
SD
uo28hrov u7
23 May 23
Conflict minerals disclosure
5:04pm
8-K
hyggrhdfk
26 Apr 23
Nevro Reports First Quarter 2023 Financial Results, Provides Second Quarter Guidance and Reiterates Full-Year 2023 Guidance
4:13pm
S-8
ibgutn0btr7v7oa b1s
21 Apr 23
Registration of securities for employees
4:36pm
8-K
1pi4m50r9kiwbok7fq36
19 Apr 23
Results of Operations and Financial Condition
5:07pm
DEFA14A
crdia11
12 Apr 23
Additional proxy soliciting materials
4:55pm
S-8
lit jq2nx3xnganf
21 Feb 23
Registration of securities for employees
7:15am
8-K
yeqp8ejjyngc6hgza45h
16 Feb 23
Nevro Announces Fourth Quarter and Full-Year 2022 Financial Results
4:11pm
8-K
mljp636u kjjf
9 Jan 23
Nevro Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2022 Revenue and Provides Full-Year 2023 Revenue Guidance
6:05am
8-K
4jw808tnq9i0dm2
2 Nov 22
Nevro Reports Third Quarter 2022 Financial Results, Narrows Full-Year 2022 Guidance and Raises Revenue Contribution from Painful Diabetic Neuropathy
4:14pm
8-K
e77lphse95vhmd5wg4ql
9 Sep 22
Departure of Directors or Certain Officers
4:49pm
8-K
k08 nr39deqvbevf
3 Aug 22
Nevro Reports Second Quarter 2022 Financial Results, Provides Third Quarter 2022 Guidance and Updates Full-Year 2022 Guidance
4:18pm
8-K
hkaxjsae46dp2br1n2v
1 Aug 22
Other Events
7:11am
8-K
c7jnr
31 May 22
Submission of Matters to a Vote of Security Holders
5:00pm
SD
wyuu6u2iojnbqp8q
23 May 22
Conflict minerals disclosure
4:50pm